
A study investigated the association between insulin-like growth-factor binding protein-2 (IGFBP-2) and early metabolic alterations in apparently healthy individuals. The study included 333 middle-aged men and women without cardiovascular symptoms. Participants with low IGFBP-2 levels had higher body fat mass, insulin resistance, and unfavorable lipid profiles. IGFBP-2 levels were inversely correlated with liver fat content in both sexes. Furthermore, IGFBP-2 concentrations were associated with hepatic fat fraction independently of age and visceral adipose tissue. These findings suggest that low IGFBP-2 levels are linked to a deteriorated cardiometabolic risk profile and increased hepatic fat content in asymptomatic individuals. Further research is needed to explore the relationship between IGFBP-2 and liver fat accumulation.
Like
Save
Share